Bionik Laboratories Corp. Stock
Stocks
BNKL
US09074A2087
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time
OTC Markets
09:51:08 2025-03-14 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -99.90% |
|
-.--% | +9,900.00% |
| 23-06-27 | Bionik Laboratories Corp. Announces Executive Changes | CI |
| 23-06-21 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| Market Cap | 12 10.59 10.02 9.09 17.04 1.15K 17.2 120.2 46.33 588 45.06 44.08 1.89K | P/E 2022 |
-0.21x | P/E 2023 | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98M 1.75M 1.66M 1.5M 2.82M 190M 2.85M 19.88M 7.66M 97.26M 7.45M 7.29M 313M | EV / Sales 2022 |
0.17x | EV / Sales 2023 | 2.65x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -99.90% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.26 | |
| 5 years | 0 | 2.9 | |
| 10 years | 0 | 222.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 46 | 2021-07-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Michal Prywata
BRD | Director/Board Member | 35 | 2019-03-17 |
| Director/Board Member | 70 | 2017-08-31 | |
Richard Russo
BRD | Director/Board Member | 46 | 2022-10-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/13/23 | Conversion | Chairman | 186,112 | 1.4416% | ||
| 6/13/23 | Conversion | Director | 3,102,878 | 24.0337% | ||
| 6/9/23 | Buy | Director | 180,555 | 1.3985% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -99.90% | -.--% | -.--% | -99.96% | 1.26K | ||
| -0.59% | +2.35% | +45.88% | +33.16% | 251B | ||
| -1.24% | +1.51% | +20.62% | -9.54% | 160B | ||
| -1.58% | +1.37% | -7.20% | +39.45% | 147B | ||
| -1.80% | -3.62% | -55.38% | -18.00% | 63.93B | ||
| -0.22% | -2.42% | +12.23% | +25.04% | 50.05B | ||
| -0.19% | +4.59% | +41.36% | +56.44% | 49.4B | ||
| -0.05% | +3.26% | -15.24% | -19.48% | 48.94B | ||
| -0.40% | +3.61% | +52.40% | +60.86% | 43.52B | ||
| -1.00% | +8.45% | +192.13% | +95.50% | 41.06B | ||
| Average | -10.72% | +3.82% | +28.68% | +16.35% | 85.41B | |
| Weighted average by Cap. | -0.92% | +4.07% | +26.09% | +24.68% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.27M 1.12M 1.06M 965K 1.81M 122M 1.83M 12.76M 4.92M 62.41M 4.78M 4.68M 201M | 1.81M 1.59M 1.51M 1.37M 2.56M 173M 2.59M 18.08M 6.97M 88.45M 6.78M 6.63M 285M |
| Net income | -10.41M -9.19M -8.69M -7.88M -14.78M -999M -14.92M -104M -40.18M -510M -39.08M -38.23M -1.64B | -4.95M -4.36M -4.13M -3.75M -7.02M -475M -7.09M -49.54M -19.09M -242M -18.57M -18.17M -780M |
| Net Debt | -1.99M -1.76M -1.66M -1.51M -2.83M -191M -2.86M -19.95M -7.69M -97.58M -7.48M -7.31M -314M | 1.98M 1.75M 1.66M 1.5M 2.82M 190M 2.85M 19.88M 7.66M 97.26M 7.45M 7.29M 313M |
Employees
-
- Stock Market
- Stocks
- BNKL Stock
Select your edition
All financial news and data tailored to specific country editions
















